NYSE: TMO
Thermo Fisher Scientific Inc Stock

$531.85-0.79 (-0.15%)
Updated Feb 14, 2025
TMO Price
$531.85
Fair Value Price
N/A
Market Cap
$203.43B
52 Week Low
$493.30
52 Week High
$627.88
P/E
33.26x
P/B
4.15x
P/S
5.54x
PEG
1.35x
Dividend Yield
0.29%
Revenue
$42.37B
Earnings
$6.14B
Gross Margin
40.8%
Operating Margin
19.45%
Profit Margin
14.5%
Debt to Equity
1.05
Operating Cash Flow
$9B
Beta
0.79
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TMO Overview

Thermo Fisher Scientific Incorporated offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. Its products and services are sold through a direct sales force, customer-service professionals, e-commerce, third-party distributors, and catalogs. It has an alliance with the University of California. Thermo Fisher was incorporated in 1956 and is based in Waltham, MA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine TMO's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

B
Value
C
Growth
C
Momentum
C
Sentiment
A
Safety
B
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Diagnostic & Research

Industry Rating
B
TMO
Ranked
#9 of 53

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$100.24A
$246.49B
$173.39B
View Top Diagnostic & Research Stocks

Be the first to know about important TMO news, forecast changes, insider trades & much more!

TMO News

Overview

Due Diligence Score

–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TMO scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TMO ($531.85) is trading above its intrinsic value of $214.63, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TMO is good value based on its earnings relative to its share price (33.26x), compared to the US market average (37.92x)
P/E vs Market Valuation
TMO is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more TMO due diligence checks available for Premium users.

Valuation

TMO price to earnings (PE)

For valuing profitable companies with steady earnings

Company
33.26x
Industry
21.72x
Market
37.92x
TMO is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TMO is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

TMO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.15x
Industry
3.88x
TMO is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TMO price to earnings growth (PEG)

For valuing profitable companies with growth potential

TMO is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

TMO's financial health

Profit margin

Revenue
$10.6B
Net Income
$1.6B
Profit Margin
15.4%
TMO's Earnings (EBIT) of $8.24B... subscribe to Premium to read more.
Interest Coverage Financials
TMO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$100.4B
Liabilities
$51.4B
Debt to equity
1.05
TMO's short-term assets ($23.78B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TMO's long-term liabilities ($36.79B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TMO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
TMO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$2.2B
Investing
-$3.6B
Financing
-$1.2B
TMO's operating cash flow ($9.10B)... subscribe to Premium to read more.
Debt Coverage Financials

TMO vs Diagnostic & Research Stocks

TickerZen RatingMarket Cap1d %P/EP/B
TMOB$203.43B-0.15%33.26x4.15x
DHRC$149.01B+1.33%39.00x2.90x
AB$38.46B-1.30%30.33x6.52x
IDXXC$36.40B-3.31%42.46x22.50x
IQVC$34.06B-1.33%25.55x5.61x

Thermo Fisher Scientific Stock FAQ

What is Thermo Fisher Scientific's quote symbol?

(NYSE: TMO) Thermo Fisher Scientific trades on the NYSE under the ticker symbol TMO. Thermo Fisher Scientific stock quotes can also be displayed as NYSE: TMO.

If you're new to stock investing, here's how to buy Thermo Fisher Scientific stock.

What is the 52 week high and low for Thermo Fisher Scientific (NYSE: TMO)?

(NYSE: TMO) Thermo Fisher Scientific's 52-week high was $627.88, and its 52-week low was $493.30. It is currently -15.29% from its 52-week high and 7.81% from its 52-week low.

How much is Thermo Fisher Scientific stock worth today?

(NYSE: TMO) Thermo Fisher Scientific currently has 382,500,265 outstanding shares. With Thermo Fisher Scientific stock trading at $531.85 per share, the total value of Thermo Fisher Scientific stock (market capitalization) is $203.43B.

Thermo Fisher Scientific stock was originally listed at a price of $44.00 in Dec 31, 1997. If you had invested in Thermo Fisher Scientific stock at $44.00, your return over the last 27 years would have been 1,108.75%, for an annualized return of 9.67% (not including any dividends or dividend reinvestments).

How much is Thermo Fisher Scientific's stock price per share?

(NYSE: TMO) Thermo Fisher Scientific stock price per share is $531.85 today (as of Feb 14, 2025).

What is Thermo Fisher Scientific's Market Cap?

(NYSE: TMO) Thermo Fisher Scientific's market cap is $203.43B, as of Feb 17, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Thermo Fisher Scientific's market cap is calculated by multiplying TMO's current stock price of $531.85 by TMO's total outstanding shares of 382,500,265.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.